YPB countering fake cannabis consumables
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
It’s hard to find an industry that’s set to deliver such rapid and consistent growth as legal cannabis and even more so, cannabis consumables.
Consumables, or “edibles”, include obvious yummies, brownies, and cookies, as well as things like cannabis-butters, oils, and cannabis-infused beverages, plus a wide range of tinctures, sprays and inhalers.
And that’s just the tip of the iceberg — as CBD and THC rapidly make their way into all kinds of consumables.
While the sector is still figuring out what products will be its future growth drivers, a crop of new cannabis edibles, extracts and concentrates are set to hit the market.
And a significant market it is. According to Deloitte, the Canadian market for edibles and alternative cannabis products is worth C$2.7 billion annually with growth set to accelerate when Canada brings in “Legislation 2.0” in October in.
Health Canada recently released details around this legalisation specifying that edibles and topicals (lotions, balms, creams, etc.), concentrates and extracts are all set to become legal in Canada in just a few months.
YPB safeguarding consumers
ASX junior, YPB Group Ltd (ASX:YPB), has its eye on this market, providing much needed consumer protections against fake and counterfeit cannabis products and the proliferation of synthetic cannabinoids.
Synthetic cannabinoids — suspected to have been contaminated with rat poison — was responsible for the deaths of three people in Illinois last year and caused severe bleeding in more than 100 people across US states.
To counter dangers like these from illegal drug labs YPB provides product authentication. Its product markers are designed to both protect consumers from the health, safety and quality risks associated with counterfeit products. It also provides consumer engagement solutions and greater market intelligence.
The company today announced that it has signed on its first client in the high volume, fast-growing cannabis consumables space.
The deal involves a Master Supply Agreement signed with cannabis extraction specialist Halo Labs Inc.
Headquartered in Canada, Halo is a cannabis grower and processor that’s listed on several exchanges — its primary listing being on Canada’s NEO exchange, while it has significant operations in the USA.
The company, an expert in oils and concentrates, is launching innovative cannabis products and delivery systems. It’s a white label manufacturer for a number of prominent cannabis brands and is also developing its own brands in a number of markets.
Within consumables, Halo’s areas of expertise, cannabis oils and concentrates, are the fastest-growing segments.
YPB will provide Halo with its authentication solutions and its YPB Connect consumer engagement platform.
YPB’s revenue under the agreement with Halo will be two-pronged:
- Authentication tracer and labels will be charged on a per unit volume basis; and
- Connect consumer engagement technology will be provided on a SaaS basis and charged monthly over the life of the contract.
The volume pricing component will allow YPB to participate in Halo’s growth.
Halo will deploy YPB’s technology on both its delivery systems and consumables products, from late Q3 2019 and is expected to become an important client to YPB over time.
YPB’s original cannabis clients signed in 2018 were all vendors of delivery systems i.e. hardware. Halo is the first client in the much higher volume, much faster-growing cannabis consumables space.
YPB Executive Chairman, John Houston, commented on the deal:
“I’m delighted YPB will be assisting Halo in ensuring its investment in brand building is not damaged by fakes and in developing the value and loyalty of its consumer base through personalised engagement direct to its consumers’ smartphones.
“After an initial flurry in H2 2018, our momentum in cannabis had slowed for a number of reasons but cannabis remains a key vertical and major opportunity for YPB. This new relationship with Halo is the first evidence of our rekindled momentum in the sector”.
While this is the first cannabis consumables agreement signed by YPB, the group already has a number of sales agreements to provide its product markers for cannabis products such as vaporisers and other accessories.
Like questionable cannabis, black market products including vapes and cartridge concentrates are also an issue for in industry. Almost all major vaporiser brands have counterfeit versions in the market.
For this market, YBP provide an industry-wide authentication and consumer engagement solution called “Cannabis Confirmed”.
The Cannabis Confirmed initiative seeks to stamp out fakes by enabling cannabis brand customers to confirm the authenticity of their product after purchasing online by scanning a unique serialised QR code — a ProtectCode — on the product packaging.
Earlier this year YPB and its partner Namaste Technologies (TSXV:N) — a global leader in cannabis e-commerce — agreed to broaden the use of YPB’s product markers to all products on Namaste’s e-commerce platforms.
There are currently four Namaste companies engaged in YPB’s initiative, including Shatterizer Inc. — an established Canadian vaporiser brand leading in hardware for cannabis concentrates. YPB has a three-year deal exclusive agreement with Shatterizer, whereby YPB’s ProtectCode will be applied to all of its cannabis concentrates vaporisers and accessories.
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.